Ralph Lipp, Ph.D.President and CEO at Lipp Life Sciences LLC
Ralph Lipp, Ph.D. is President and CEO of Lipp Life Sciences LLC where his focuses on helping his clients elevate innovation and create value. Previously, as Chief Scientific Officer at Noven Pharmaceuticals he provided leadership to all research and development areas. At Schering where he started his industry career and later at Eli Lilly he headed various R&D functions with increasing responsibility for people and budget – up to 450 FTEs and up to $250 million. Ralph has been working in drug delivery for more than 25 years and his scientific contributions comprise more than 140 publications, including over 20 patents, covering five marketed medicines with aggregate peak annual sales exceeding $1 billion. Ralph holds a Ph.D. in Medicinal Chemistry and a Habilitation for Pharmaceutical Technology from Free University Berlin, Germany. He graduated from the International Executive Program, at INSEAD in Fontainebleau, France and from the Advanced Management Program, at Harvard Business School, Boston, MA, USA.